مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

379
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

233
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

PREVENTIVE EFFECT OF CLOFIBRATE ON NEONATAL HYPERBILIRUBINEMIA

Pages

  5-8

Abstract

 Background: NEONATAL JAUNDICE is a common problem that can result in serious neurological side effect such as Kern icterus. Several drugs are used to prevent NEONATAL JAUNDICE. The effect of CLOFIBRATE in the PREVENTION of hyperbilirubinemia in healthy term neonates has not been paid attention to. This study aimed to evaluate the preventive effect of CLOFIBRATE on NEONATAL JAUNDICE in term neonates.Methods: This clinical trial was conducted on 80 healthy newborns randomly divided in to cases and control groups. The case group received CLOFIBRATE (50 mg/kg of body weight) orally in the first hour after birth and after the first period of breastfeeding. Serum bilirubin levels were measured in cord blood and again at 24, 48 and 72 hours after birth in both groups and were compared.Babies with clear JAUNDICE on the first day, direct NEONATAL JAUNDICE>1 mg/dl, sick infants, and infants of mothers treated with phenobarbital and preterm infants weighing less than 2500 gr were excluded.Results: The mean bilirubin level in cord blood and its level at 24, 48 and 72 hours after birth in control groups were 1.99±0.46, 2.88±0.88, 5.94±1.15, 7.65±1.69, respectively and in the case group were 2.12±0.75, 2.89±0.95, 5.8±1.16, 7.18±1.57, respectively. Thus, the mean bilirubin in the case group is lower, but it was not statistically significant. Also, sex distribution, Rh-blood group incompatibility and G6PD deficiency in both groups showed no significant difference.Conclusions: Our results showed that prophylactic CLOFIBRATE application reduced NEONATAL hyperbilirubinemia, but wasn’t statistically significant.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    ZAHED PASHA, YADOLLAH, MAHDIPOUR, SADRODDIN, AHMADPOUR KACHO, MOUSA, BIJANI, ALI, & TAHERI, MARYAM. (2015). PREVENTIVE EFFECT OF CLOFIBRATE ON NEONATAL HYPERBILIRUBINEMIA. CASPIAN JOURNAL OF PEDIATRICS, 1(1), 5-8. SID. https://sid.ir/paper/348291/en

    Vancouver: Copy

    ZAHED PASHA YADOLLAH, MAHDIPOUR SADRODDIN, AHMADPOUR KACHO MOUSA, BIJANI ALI, TAHERI MARYAM. PREVENTIVE EFFECT OF CLOFIBRATE ON NEONATAL HYPERBILIRUBINEMIA. CASPIAN JOURNAL OF PEDIATRICS[Internet]. 2015;1(1):5-8. Available from: https://sid.ir/paper/348291/en

    IEEE: Copy

    YADOLLAH ZAHED PASHA, SADRODDIN MAHDIPOUR, MOUSA AHMADPOUR KACHO, ALI BIJANI, and MARYAM TAHERI, “PREVENTIVE EFFECT OF CLOFIBRATE ON NEONATAL HYPERBILIRUBINEMIA,” CASPIAN JOURNAL OF PEDIATRICS, vol. 1, no. 1, pp. 5–8, 2015, [Online]. Available: https://sid.ir/paper/348291/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button